Al in Biotechnology Market by Function (Drug Design & Optimisation, Biomarker, SAR; Clinical Trial Design, Data Assessment, RWE, Inventory, Supply chain, Logistics; Launch, Pricing, Patient Engagement, Adverse Events), & End User - Global Forecast to 2029

Al in Biotechnology Market by Function (Drug Design & Optimisation, Biomarker, SAR; Clinical Trial Design, Data Assessment, RWE, Inventory, Supply chain, Logistics; Launch, Pricing, Patient Engagement, Adverse Events), & End User - Global Forecast to 2029

The global AI in biotechnology market is projected to reach USD 7.75 billion by 2029 from USD 3.23 billion in 2024, at a high CAGR of 19.1% during the forecast period. The market is expected to grow as a result of the increasing demand for personalized therapies and precision medicines, and the growing applications of AI in epidemiological models for predicting disease outbreaks. It helps public health officials to respond and develop better vaccines which further drives market growth. The increasing demand for personalized therapies and precision medicine has led to an increasing number of clinical trials performed. For instance, as of October 2023, around 1584 clinical trials performed using AI for various diseases were reported to Clincaltrials.gov. However, the limited interpretability of AI algorithms, high implementation cost and data privacy & security concerns are some of the restraining factors for the market growth.

“Based on function, research & development segment dominated the AI in biotechnology market in 2023”

The AI in biotechnology market by function is broadly divided into six segments: research & development, regulatory compliance, manufacturing & supply chain, launch & commercial, and post-market surveillance & patient support. The research & development segment accounted for the largest share of the global AI in biotechnology market in 2023. The large share of this segment can be attributed to the rising demand for personalized medicine, automation in labs, the rise of predictive analytics, and the need for faster drug discovery. an increase in the number of AI-discovered molecules in clinical trials significantly augments market growth. For instance, AI-native Biotechs and their partners in the pharmaceutical industry have entered an increasing number of molecules for AI-driven clinical trials (Source: Elsevier B.V.). In 2023, there were around 67 reported ongoing trials, and this number has increased from 2014 with around 60% year-over-year compound growth.

“In 2023, the pharmaceutical companies held the largest market share among end users.”

Based on end user, pharmaceutical companies hold the largest share of the AI in biotechnology market. There are emerging health problems, notably cognitive decline that led to high healthcare services and medication demands, associated with such demographic shifts. Pharmaceutical companies will experience huge growth opportunities as life expectancy increases, thereby raising the increasing healthcare demands of this aging population. Additionally, massive investments are being made by pharmaceutical companies into research and development, particularly drug discovery and development processes wherein AI is utilized for tasks like target identification, lead optimization, and patient stratification in clinical trials.

“In 2023, Europe was the second largest regional market for AI in the biotechnology market.”

In 2023, Europe held the second-highest share of the AI in biotechnology market. This dominance is attributed to a substantial increase in investment in Europe for AI, with a growing number of patent filings for biotechnology-related medical technology. In the year 2022, the European Patent Office (EPO) published over 10,000 AI patent applications, which highlights an increased focus on AI solutions in biotechnology. In March 2023, the UK government pledged investment in nine promising AI healthcare technologies to speed up research and development. Moreover, in August 2023, the government launched 22 new projects to explore the application of AI in healthcare. All these initiatives represent Europe's determination to spearhead applications of AI in the biotechnology sector.

The break-down of primary participants is as mentioned below:

By Company Type - Tier 1: 45%, Tier 2: 30%, and Tier 3: 25%

By Designation - C-level: 42%, Director-level: 31%, and Others: 27%

By Region - North America: 32%, Europe: 32%, Asia Pacific: 26%, Middle East & Africa: 5%, Latin America: 5%

NVIDIA Corporation (US), Illumina, Inc. (US), Exscientia plc (UK), Schrödinger, Inc. (US), Recursion Pharmaceuticals, Inc. (US), SOPHiA GENETICS (Switzerland), Predictive Oncology. (US), Deep Genomics. (Canada), ), Data4Cure, Inc. (US), Genoox (US), BenevolentAI (US), and DNAnexus, Inc. (US) are some of the key players in the AI in biotechnology market.

The study includes an in-depth competitive analysis of these key players in AI in biotechnology market, with their company profiles, recent developments, and key market strategies.

Research Coverage:

The report analyses the AI in biotechnology market. It aims to estimate the market size and future growth potential of various market segments based on offering (end-to-end solutions, niche solutions, technology providers, and services), function (research & development [R&D], regulatory compliance, manufacturing & supply chain, launch & commercial, post-market surveillance & patient support, and corporate), deployment mode (cloud-based, and on-premise), end-user (pharmaceutical companies, biotechnology companies, research institutes and labs, healthcare providers, and contract research organizations [CRO]), and region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa).

The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the AI in biotechnology market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; partnerships, collaborations, acquisitions, expansion, agreements, investment, and product launches associated with the AI in biotechnology market. Competitive analysis of upcoming startups in the AI in biotechnology market ecosystem is covered in this report.

Reasons to Buy the Report

This report will enrich established firms and new entrants/smaller firms to gauge the market's pulse, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:

Analysis of key drivers: (growing cross-industry collaborations and partnerships, growing need to reduce the time and cost of drug discovery and development, rising adoption of AI in precision medicine, improving computing power, and declining hardware cost), restraints (high implementation costs of AI limit adoption in biotechnology, especially for SMEs and emerging economies, data privacy risks and compliance challenges for AI in biotechnology), opportunities (integrating AI and big data in precision medicine for biotechnology advancement, surge in biotechnology investments enhances opportunities for AI to accelerate drug discovery innovations, innovation across healthcare, agriculture, and environmental science for global growth), and challenges (data quality and interpretability issues that hinder AI integration and trustworthiness, AI deployment in biotechnology hindered by talent shortages and evolving regulatory challenges) influencing the growth of the AI in biotechnology market.

Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the AI in biotechnology market.

Market Development: Comprehensive information on the lucrative emerging markets, by offering, function, deployment mode, end-user, and region.

Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the AI in biotechnology market.

Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the AI in biotechnology market including NVIDIA Corporation (US), Illumina, Inc. (US), Exscientia (UK), Schrödinger, Inc. (US), Recursion Pharmaceuticals, Inc. (US), SOPHiA GENETICS (Switzerland), Predictive Oncology. (US),Deep Genomics. (Canada), Exscientia (US), and Data4Cure, Inc.

Tables List

Table 1 Exchange Rates Utilized For Conversion To Usd

Table 2 Indicative List Of Collaborations And Partnerships In Ai In Biotechnology Market (2021−2024)

Table 3 Ai In Biotechnology Market: Porter’s Five Forces Analysis

Table 4 North America: Regulatory Bodies, Government Agencies, And Other Organizations

Table 5 Europe: Regulatory Bodies, Government Agencies, And Other Organizations

Table 6 Asia Pacific: Regulatory Bodies, Government Agencies, And Other Organizations

Table 7 Rest Of The World: Regulatory Bodies, Government Agencies, And Other Organizations

Table 8 List Of Patents/Patent Applications In Ai In Biotechnology Market, 2021–2024

Table 9 Ai In Biotechnology Market: Indicative Pricing, By Drug Discovery Process

Table 10 Ai In Biotechnology Market: Key Conferences & Events, 2024–2025

Table 11 Influence Of Stakeholders On Buying Process Of Top 3 End Users (%)

Table 12 Key Buying Criteria For Top 3 End Users

Table 13 Unmet Needs In Ai In Biotechnology Market

Table 14 End-user Expectations In Ai In Biotechnology Market

Table 15 Ai In Biotechnology Market, By Offering, 2022–2029 (Usd Million)

Table 16 Ai In Biotechnology Market For End-to-end Solutions, By Region,

2022–2029 (Usd Million)

Table 17 Ai In Biotechnology Market For Niche Solutions, By Region,

2022–2029 (Usd Million)

Table 18 Ai In Biotechnology Market For Technologies, By Region,

2022–2029 (Usd Million)

Table 19 Ai In Biotechnology Market For Services, By Type,

2022–2029 (Usd Million)

Table 20 Ai In Biotechnology Market For Services, By Region,

2022–2029 (Usd Million)

Table 21 Ai In Biotechnology Market For Consulting Services, By Region,

2022–2029 (Usd Million)

Table 22 Ai In Biotechnology Market For Implementation Services & Ongoing

It Support, By Region, 2022–2029 (Usd Million)

Table 23 Ai In Biotechnology Market For Training & Education Services,

By Region, 2022–2029 (Usd Million)

Table 24 Ai In Biotechnology Market For Post-sales & Maintenance Services,

By Region, 2022–2029 (Usd Million)

Table 25 Ai In Biotechnology Market, By Function, 2022–2029 (Usd Million)

Table 26 Ai In Biotechnology Market For Research & Development Functions,

By Type, 2022–2029 (Usd Million)

Table 27 Ai In Biotechnology Market For Research & Development Functions,

By Region, 2022–2029 (Usd Million)

Table 28 Examples Of Ai Tools Used In Drug Discovery

Table 29 Ai In Biotechnology Market For Drug Discovery, By Type,

2022–2029 (Usd Million)

Table 30 Ai In Biotechnology Market For Drug Discovery, By Region,

2022–2029 (Usd Million)

Table 31 Ai In Biotechnology Market For Molecular Design & Optimization,

By Region, 2022–2029 (Usd Million)

Table 32 Ai In Biotechnology Market For Biomarker Discovery, By Region,

2022–2029 (Usd Million)

Table 33 Ai In Biotechnology Market For Structure-activity Relationship (Sar) Modeling, By Region, 2022–2029 (Usd Million)

Table 34 Ai In Biotechnology Market For Clinical Development, By Type,

2022–2029 (Usd Million)

Table 35 Ai In Biotechnology Market For Clinical Development, By Region,

2022–2029 (Usd Million)

Table 36 Ai In Biotechnology Market For Trial Design, By Region,

2022–2029 (Usd Million)

Table 37 Ai In Biotechnology Market For Site Selection, By Region,

2022–2029 (Usd Million)

Table 38 Ai In Biotechnology Market For Recruitment, By Region,

2022–2029 (Usd Million)

Table 39 Ai In Biotechnology Market For Clinical Data Assessment, By Region, 2022–2029 (Usd Million)

Table 40 Ai In Biotechnology Market For Predictive Toxicity & Risk Monitoring, By Region, 2022–2029 (Usd Million)

Table 41 Ai In Biotechnology Market For Monitoring & Drug Adherence,

By Region, 2022–2029 (Usd Million)

Table 42 Ai In Biotechnology Market For Real-world Evidence (Rwe) Analysis,

By Region, 2022–2029 (Usd Million)

Table 43 Ai In Biotechnology Market For Regulatory Compliance Functions,

By Region, 2022–2029 (Usd Million)

Table 44 Ai In Biotechnology Market For Manufacturing & Supply Chain Functions, By Type, 2022–2029 (Usd Million)

Table 45 Ai In Biotechnology Market For Manufacturing & Supply Chain Functions, By Region, 2022–2029 (Usd Million)

Table 46 Ai In Biotechnology Market For Supply Chain Planning, By Region, 2022–2029 (Usd Million)

Table 47 Ai In Biotechnology Market For Inventory Management, By Region, 2022–2029 (Usd Million)

Table 48 Ai In Biotechnology Market For Logistics Optimization, By Region,

2022–2029 (Usd Million)

Table 49 Ai In Biotechnology Market For Demand Forecasting, By Region,

2022–2029 (Usd Million)

Table 50 Ai In Biotechnology Market For Predictive Maintenance, By Region, 2022–2029 (Usd Million)

Table 51 Ai In Biotechnology Market For Other Manufacturing & Supply Chain Functions, By Region, 2022–2029 (Usd Million)

Table 52 Ai In Biotechnology Market For Launch & Commercial Functions,

By Type, 2022–2029 (Usd Million)

Table 53 Ai In Biotechnology Market For Launch & Commercial Functions,

By Region, 2022–2029 (Usd Million)

Table 54 Ai In Biotechnology Market For Launch Coordination, By Region,

2022–2029 (Usd Million)

Table 55 Ai In Biotechnology Market For Patient Engagement, By Region,

2022–2029 (Usd Million)

Table 56 Ai In Biotechnology Market For Marketing Operations, By Region, 2022–2029 (Usd Million)

Table 57 Ai In Biotechnology Market For Predictive Pricing, By Region,

2022–2029 (Usd Million)

Table 58 Ai In Biotechnology Market For Post-marketing Surveillance & Patient Support Functions, By Type, 2022–2029 (Usd Million)

Table 59 Ai In Biotechnology Market For Post-marketing Surveillance & Patient Support Functions, By Region, 2022–2029 (Usd Million)

Table 60 Ai In Biotechnology Market For Medication Adherence, By Region, 2022–2029 (Usd Million)

Table 61 Ai In Biotechnology Market For Adverse Event Reporting, By Region, 2022–2029 (Usd Million)

Table 62 Ai In Biotechnology Market For Patient Monitoring, By Region,

2022–2029 (Usd Million)

Table 63 Ai In Biotechnology Market For Compliance Monitoring, By Region, 2022–2029 (Usd Million)

Table 64 Ai In Biotechnology Market For Patient Support Programs, By Region, 2022–2029 (Usd Million)

Table 65 Ai In Biotechnology Market For Corporate Functions, By Type,

2022–2029 (Usd Million)

Table 66 Ai In Biotechnology Market For Corporate Functions, By Region,

2022–2029 (Usd Million)

Table 67 Ai In Biotechnology Market For Risk Management, By Region,

2022–2029 (Usd Million)

Table 68 Ai In Biotechnology Market For Compliance Monitoring, By Region, 2022–2029 (Usd Million)

Table 69 Ai In Biotechnology Market For Sales Force Optimization, By Region, 2022–2029 (Usd Million)

Table 70 Ai In Biotechnology Market For Other Corporate Functions, By Region, 2022–2029 (Usd Million)

Table 71 Ai In Biotechnology Market, By Deployment Mode,

2022–2029 (Usd Million)

Table 72 Ai In Biotechnology Market For Cloud-based Solutions, By Type,

2022–2029 (Usd Million)

Table 73 Ai In Biotechnology Market For Cloud-based Solutions, By Region, 2022–2029 (Usd Million)

Table 74 Ai In Biotechnology Market For Public Cloud, By Region,

2022–2029 (Usd Million)

Table 75 Ai In Biotechnology Market For Private Cloud, By Region,

2022–2029 (Usd Million)

Table 76 Ai In Biotechnology Market For Multi-cloud, By Region,

2022–2029 (Usd Million)

Table 77 Ai In Biotechnology Market For Hybrid Cloud, By Region,

2022–2029 (Usd Million)

Table 78 Ai In Biotechnology Market For On-premise Solutions, By Region,

2022–2029 (Usd Million)

Table 79 Ai In Biotechnology Market, By End User, 2022–2029 (Usd Million)

Table 80 Ai In Biotechnology Market For Pharmaceutical Companies, By Region, 2022–2029 (Usd Million)

Table 81 Ai In Biotechnology Market For Biotechnology Companies, By Region, 2022–2029 (Usd Million)

Table 82 Ai In Biotechnology Market For Research Institutes & Labs, By Region, 2022–2029 (Usd Million)

Table 83 Ai In Biotechnology Market For Healthcare Providers, By Region, 2022–2029 (Usd Million)

Table 84 Ai In Biotechnology Market For Contract Research Organizations (Cros), By Region, 2022–2029 (Usd Million)

Table 85 Ai In Biotechnology Market, By Region, 2022–2029 (Usd Million)

Table 86 North America: Ai In Biotechnology Market, By Country,

2022–2029 (Usd Million)

Table 87 North America: Ai In Biotechnology Market, By Offering,

2022–2029 (Usd Million)

Table 88 North America: Ai In Biotechnology Market For Services, By Type,

2022–2029 (Usd Million)

Table 89 North America: Ai In Biotechnology Market, By Function,

2022–2029 (Usd Million)

Table 90 North America: Ai In Biotechnology Market For Research & Development Functions, By Type, 2022–2029 (Usd Million)

Table 91 North America: Ai In Biotechnology Market For Drug Discovery,

By Type, 2022–2029 (Usd Million)

Table 92 North America: Ai In Biotechnology Market For Clinical Development, By Type, 2022–2029 (Usd Million)

Table 93 North America: Ai In Biotechnology Market For Manufacturing & Supply Chain Functions, By Type, 2022–2029 (Usd Million)

Table 94 North America: Ai In Biotechnology Market For Launch & Commercial Functions, By Type, 2022–2029 (Usd Million)

Table 95 North America: Ai In Biotechnology Market For Post-marketing Surveillance & Patient Support Functions, By Type,

2022–2029 (Usd Million)

Table 96 North America: Ai In Biotechnology Market For Corporate Functions, By Type, 2022–2029 (Usd Million)

Table 97 North America: Ai In Biotechnology Market, By Deployment Mode, 2022–2029 (Usd Million)

Table 98 North America: Ai In Biotechnology Market For Cloud-based Solutions, By Type, 2022–2029 (Usd Million)

Table 99 North America: Ai In Biotechnology Market, By End User,

2022–2029 (Usd Million)

Table 100 Us: Ai In Biotechnology Market, By Offering, 2022–2029 (Usd Million)

Table 101 Us: Ai In Biotechnology Market For Services, By Type,

2022–2029 (Usd Million)

Table 102 Us: Ai In Biotechnology Market, By Function, 2022–2029 (Usd Million)

Table 103 Us: Ai In Biotechnology Market For Research & Development Functions, By Type, 2022–2029 (Usd Million)

Table 104 Us: Ai In Biotechnology Market For Drug Discovery, By Type,

2022–2029 (Usd Million)

Table 105 Us: Ai In Biotechnology Market For Clinical Development, By Type, 2022–2029 (Usd Million)

Table 106 Us: Ai In Biotechnology Market For Manufacturing & Supply Chain Functions, By Type, 2022–2029 (Usd Million)

Table 107 Us: Ai In Biotechnology Market For Launch & Commercial Functions,

By Type, 2022–2029 (Usd Million)

Table 108 Us: Ai In Biotechnology Market For Post-marketing Surveillance & Patient Support Functions, By Type, 2022–2029 (Usd Million)

Table 109 Us: Ai In Biotechnology Market For Corporate Functions, By Type, 2022–2029 (Usd Million)

Table 110 Us: Ai In Biotechnology Market, By Deployment Mode,

2022–2029 (Usd Million)

Table 111 Us: Ai In Biotechnology Market For Cloud-based Solutions, By Type, 2022–2029 (Usd Million)

Table 112 Us: Ai In Biotechnology Market, By End User, 2022–2029 (Usd Million)

Table 113 Canada: Ai In Biotechnology Market, By Offering,

2022–2029 (Usd Million)

Table 114 Canada: Ai In Biotechnology Market For Services, By Type,

2022–2029 (Usd Million)

Table 115 Canada: Ai In Biotechnology Market, By Function,

2022–2029 (Usd Million)

Table 116 Canada: Ai In Biotechnology Market For Research & Development Functions, By Type, 2022–2029 (Usd Million)

Table 117 Canada: Ai In Biotechnology Market For Drug Discovery, By Type,

2022–2029 (Usd Million)

Table 118 Canada: Ai In Biotechnology Market For Clinical Development, By Type, 2022–2029 (Usd Million)

Table 119 Canada: Ai In Biotechnology Market For Manufacturing & Supply Chain Functions, By Type, 2022–2029 (Usd Million)

Table 120 Canada: Ai In Biotechnology Market For Launch & Commercial Functions, By Type, 2022–2029 (Usd Million)

Table 121 Canada: Ai In Biotechnology Market For Post-marketing Surveillance & Patient Support Functions, By Type, 2022–2029 (Usd Million)

Table 122 Canada: Ai In Biotechnology Market For Corporate Functions, By Type, 2022–2029 (Usd Million)

Table 123 Canada: Ai In Biotechnology Market, By Deployment Mode,

2022–2029 (Usd Million)

Table 124 Canada: Ai In Biotechnology Market For Cloud-based Solutions,

By Type, 2022–2029 (Usd Million)

Table 125 Canada: Ai In Biotechnology Market, By End User,

2022–2029 (Usd Million)

Table 126 Europe: Ai In Biotechnology Market, By Country,

2022–2029 (Usd Million)

Table 127 Europe: Ai In Biotechnology Market, By Offering,

2022–2029 (Usd Million)

Table 128 Europe: Ai In Biotechnology Market For Services, By Type,

2022–2029 (Usd Million)

Table 129 Europe: Ai In Biotechnology Market, By Function,

2022–2029 (Usd Million)

Table 130 Europe: Ai In Biotechnology Market For Research & Development Functions, By Type, 2022–2029 (Usd Million)

Table 131 Europe: Ai In Biotechnology Market For Drug Discovery, By Type,

2022–2029 (Usd Million)

Table 132 Europe: Ai In Biotechnology Market For Clinical Development, By Type, 2022–2029 (Usd Million)

Table 133 Europe: Ai In Biotechnology Market For Manufacturing & Supply Chain Functions, By Type, 2022–2029 (Usd Million)

Table 134 Europe: Ai In Biotechnology Market For Launch & Commercial Functions, By Type, 2022–2029 (Usd Million)

Table 135 Europe: Ai In Biotechnology Market For Post-marketing Surveillance & Patient Support Functions, By Type, 2022–2029 (Usd Million)

Table 136 Europe: Ai In Biotechnology Market For Corporate Functions, By Type, 2022–2029 (Usd Million)

Table 137 Europe: Ai In Biotechnology Market, By Deployment Mode,

2022–2029 (Usd Million)

Table 138 Europe: Ai In Biotechnology Market For Cloud-based Solutions,

By Type, 2022–2029 (Usd Million)

Table 139 Europe: Ai In Biotechnology Market, By End User,

2022–2029 (Usd Million)

Table 140 Germany: Ai In Biotechnology Market, By Offering,

2022–2029 (Usd Million)

Table 141 Germany: Ai In Biotechnology Market For Services, By Type,

2022–2029 (Usd Million)

Table 142 Germany: Ai In Biotechnology Market, By Function,

2022–2029 (Usd Million)

Table 143 Germany: Ai In Biotechnology Market For Research & Development Functions, By Type, 2022–2029 (Usd Million)

Table 144 Germany: Ai In Biotechnology Market For Drug Discovery, By Type, 2022–2029 (Usd Million)

Table 145 Germany: Ai In Biotechnology Market For Clinical Development,

By Type, 2022–2029 (Usd Million)

Table 146 Germany: Ai In Biotechnology Market For Manufacturing & Supply Chain Functions, By Type, 2022–2029 (Usd Million)

Table 147 Germany: Ai In Biotechnology Market For Launch & Commercial Functions, By Type, 2022–2029 (Usd Million)

Table 148 Germany: Ai In Biotechnology Market For Post-marketing Surveillance & Patient Support Functions, By Type, 2022–2029 (Usd Million)

Table 149 Germany: Ai In Biotechnology Market For Corporate Functions, By Type, 2022–2029 (Usd Million)

Table 150 Germany: Ai In Biotechnology Market, By Deployment Mode,

2022–2029 (Usd Million)

Table 151 Germany: Ai In Biotechnology Market For Cloud-based Solutions,

By Type, 2022–2029 (Usd Million)

Table 152 Germany: Ai In Biotechnology Market, By End User,

2022–2029 (Usd Million)

Table 153 Uk: Ai In Biotechnology Market, By Offering, 2022–2029 (Usd Million)

Table 154 Uk: Ai In Biotechnology Market For Services, By Type,

2022–2029 (Usd Million)

Table 155 Uk: Ai In Biotechnology Market, By Function, 2022–2029 (Usd Million)

Table 156 Uk: Ai In Biotechnology Market For Research & Development Functions, By Type, 2022–2029 (Usd Million)

Table 157 Uk: Ai In Biotechnology Market For Drug Discovery, By Type,

2022–2029 (Usd Million)

Table 158 Uk: Ai In Biotechnology Market For Clinical Development, By Type, 2022–2029 (Usd Million)

Table 159 Uk: Ai In Biotechnology Market For Manufacturing & Supply Chain Functions, By Type, 2022–2029 (Usd Million)

Table 160 Uk: Ai In Biotechnology Market For Launch & Commercial Functions,

By Type, 2022–2029 (Usd Million)

Table 161 Uk: Ai In Biotechnology Market For Post-marketing Surveillance & Patient Support Functions, By Type, 2022–2029 (Usd Million)

Table 162 Uk: Ai In Biotechnology Market For Corporate Functions, By Type, 2022–2029 (Usd Million)

Table 163 Uk: Ai In Biotechnology Market, By Deployment Mode,

2022–2029 (Usd Million)

Table 164 Uk: Ai In Biotechnology Market For Cloud-based Solutions, By Type, 2022–2029 (Usd Million)

Table 165 Uk: Ai In Biotechnology Market, By End User, 2022–2029 (Usd Million)

Table 166 France: Ai In Biotechnology Market, By Offering,

2022–2029 (Usd Million)

Table 167 France: Ai In Biotechnology Market For Services, By Type,

2022–2029 (Usd Million)

Table 168 France: Ai In Biotechnology Market, By Function,

2022–2029 (Usd Million)

Table 169 France: Ai In Biotechnology Market For Research & Development Functions, By Type, 2022–2029 (Usd Million)

Table 170 France: Ai In Biotechnology Market For Drug Discovery, By Type,

2022–2029 (Usd Million)

Table 171 France: Ai In Biotechnology Market For Clinical Development, By Type, 2022–2029 (Usd Million)

Table 172 France: Ai In Biotechnology Market For Manufacturing & Supply Chain Functions, By Type, 2022–2029 (Usd Million)

Table 173 France: Ai In Biotechnology Market For Launch & Commercial Functions, By Type, 2022–2029 (Usd Million)

Table 174 France: Ai In Biotechnology Market For Post-marketing Surveillance & Patient Support Functions, By Type, 2022–2029 (Usd Million)

Table 175 France: Ai In Biotechnology Market For Corporate Functions, By Type, 2022–2029 (Usd Million)

Table 176 France: Ai In Biotechnology Market, By Deployment Mode,

2022–2029 (Usd Million)

Table 177 France: Ai In Biotechnology Market For Cloud-based Solutions, By Type, 2022–2029 (Usd Million)

Table 178 France: Ai In Biotechnology Market, By End User,

2022–2029 (Usd Million)

Table 179 Italy: Ai In Biotechnology Market, By Offering, 2022–2029 (Usd Million)

Table 180 Italy: Ai In Biotechnology Market For Services, By Type,

2022–2029 (Usd Million)

Table 181 Italy: Ai In Biotechnology Market, By Function, 2022–2029 (Usd Million)

Table 182 Italy: Ai In Biotechnology Market For Research & Development Functions, By Type, 2022–2029 (Usd Million)

Table 183 Italy: Ai In Biotechnology Market For Drug Discovery, By Type,

2022–2029 (Usd Million)

Table 184 Italy: Ai In Biotechnology Market For Clinical Development, By Type, 2022–2029 (Usd Million)

Table 185 Italy: Ai In Biotechnology Market For Manufacturing & Supply Chain Functions, By Type, 2022–2029 (Usd Million)

Table 186 Italy: Ai In Biotechnology Market For Launch & Commercial Functions, By Type, 2022–2029 (Usd Million)

Table 187 Italy: Ai In Biotechnology Market For Post-marketing Surveillance & Patient Support Functions, By Type, 2022–2029 (Usd Million)

Table 188 Italy: Ai In Biotechnology Market For Corporate Functions, By Type, 2022–2029 (Usd Million)

Table 189 Italy: Ai In Biotechnology Market, By Deployment Mode,

2022–2029 (Usd Million)

Table 190 Italy: Ai In Biotechnology Market For Cloud-based Solutions, By Type, 2022–2029 (Usd Million)

Table 191 Italy: Ai In Biotechnology Market, By End User, 2022–2029 (Usd Million)

Table 192 Spain: Ai In Biotechnology Market, By Offering, 2022–2029 (Usd Million)

Table 193 Spain: Ai In Biotechnology Market For Services, By Type,

2022–2029 (Usd Million)

Table 194 Spain: Ai In Biotechnology Market, By Function, 2022–2029 (Usd Million)

Table 195 Spain: Ai In Biotechnology Market For Research & Development Functions, By Type, 2022–2029 (Usd Million)

Table 196 Spain: Ai In Biotechnology Market For Drug Discovery, By Type,

2022–2029 (Usd Million)

Table 197 Spain: Ai In Biotechnology Market For Clinical Development, By Type, 2022–2029 (Usd Million)

Table 198 Spain: Ai In Biotechnology Market For Manufacturing & Supply Chain Functions, By Type, 2022–2029 (Usd Million)

Table 199 Spain: Ai In Biotechnology Market For Launch & Commercial Functions, By Type, 2022–2029 (Usd Million)

Table 200 Spain: Ai In Biotechnology Market For Post-marketing Surveillance & Patient Support Functions, By Type, 2022–2029 (Usd Million)

Table 201 Spain: Ai In Biotechnology Market For Corporate Functions, By Type, 2022–2029 (Usd Million)

Table 202 Spain: Ai In Biotechnology Market, By Deployment Mode,

2022–2029 (Usd Million)

Table 203 Spain: Ai In Biotechnology Market For Cloud-based Solutions, By Type, 2022–2029 (Usd Million)

Table 204 Spain: Ai In Biotechnology Market, By End User, 2022–2029 (Usd Million)

Table 205 Rest Of Europe: Ai In Biotechnology Market, By Offering,

2022–2029 (Usd Million)

Table 206 Rest Of Europe: Ai In Biotechnology Market For Services, By Type, 2022–2029 (Usd Million)

Table 207 Rest Of Europe: Ai In Biotechnology Market, By Function,

2022–2029 (Usd Million)

Table 208 Rest Of Europe: Ai In Biotechnology Market For Research & Development Functions, By Type, 2022–2029 (Usd Million)

Table 209 Rest Of Europe: Ai In Biotechnology Market For Drug Discovery,

By Type, 2022–2029 (Usd Million)

Table 210 Rest Of Europe: Ai In Biotechnology Market For Clinical Development, By Type, 2022–2029 (Usd Million)

Table 211 Rest Of Europe: Ai In Biotechnology Market For Manufacturing & Supply Chain Functions, By Type, 2022–2029 (Usd Million)

Table 212 Rest Of Europe: Ai In Biotechnology Market For Launch & Commercial Functions, By Type, 2022–2029 (Usd Million)

Table 213 Rest Of Europe: Ai In Biotechnology Market For Post-marketing Surveillance & Patient Support Functions, By Type,

2022–2029 (Usd Million)

Table 214 Rest Of Europe: Ai In Biotechnology Market For Corporate Functions, By Type, 2022–2029 (Usd Million)

Table 215 Rest Of Europe: Ai In Biotechnology Market, By Deployment Mode, 2022–2029 (Usd Million)

Table 216 Rest Of Europe: Ai In Biotechnology Market For Cloud-based Solutions, By Type, 2022–2029 (Usd Million)

Table 217 Rest Of Europe: Ai In Biotechnology Market, By End User,

2022–2029 (Usd Million)

Table 218 Asia Pacific: Ai In Biotechnology Market, By Country,

2022–2029 (Usd Million)

Table 219 Asia Pacific: Ai In Biotechnology Market, By Offering,

2022–2029 (Usd Million)

Table 220 Asia Pacific: Ai In Biotechnology Market For Services, By Type,

2022–2029 (Usd Million)

Table 221 Asia Pacific: Ai In Biotechnology Market, By Function,

2022–2029 (Usd Million)

Table 222 Asia Pacific: Ai In Biotechnology Market For Research & Development Functions, By Type, 2022–2029 (Usd Million)

Table 223 Asia Pacific: Ai In Biotechnology Market For Drug Discovery, By Type, 2022–2029 (Usd Million)

Table 224 Asia Pacific: Ai In Biotechnology Market For Clinical Development,

By Type, 2022–2029 (Usd Million)

Table 225 Asia Pacific: Ai In Biotechnology Market For Manufacturing & Supply Chain Functions, By Type, 2022–2029 (Usd Million)

Table 226 Asia Pacific: Ai In Biotechnology Market For Launch & Commercial Functions, By Type, 2022–2029 (Usd Million)

Table 227 Asia Pacific: Ai In Biotechnology Market For Post-marketing Surveillance & Patient Support Functions, By Type,

2022–2029 (Usd Million)

Table 228 Asia Pacific: Ai In Biotechnology Market For Corporate Functions,

By Type, 2022–2029 (Usd Million)

Table 229 Asia Pacific: Ai In Biotechnology Market, By Deployment Mode,

2022–2029 (Usd Million)

Table 230 Asia Pacific: Ai In Biotechnology Market For Cloud-based Solutions,

By Type, 2022–2029 (Usd Million)

Table 231 Asia Pacific: Ai In Biotechnology Market, By End User,

2022–2029 (Usd Million)

Table 232 Japan: Ai In Biotechnology Market, By Offering, 2022–2029 (Usd Million)

Table 233 Japan: Ai In Biotechnology Market For Services, By Type,

2022–2029 (Usd Million)

Table 234 Japan: Ai In Biotechnology Market, By Function, 2022–2029 (Usd Million)

Table 235 Japan: Ai In Biotechnology Market For Research & Development Functions, By Type, 2022–2029 (Usd Million)

Table 236 Japan: Ai In Biotechnology Market For Drug Discovery, By Type,

2022–2029 (Usd Million)

Table 237 Japan: Ai In Biotechnology Market For Clinical Development, By Type, 2022–2029 (Usd Million)

Table 238 Japan: Ai In Biotechnology Market For Manufacturing & Supply Chain Functions, By Type, 2022–2029 (Usd Million)

Table 239 Japan: Ai In Biotechnology Market For Launch & Commercial Functions, By Type, 2022–2029 (Usd Million)

Table 240 Japan: Ai In Biotechnology Market, By Post-marketing Surveillance & Patient Support Functions, By Type, 2022–2029 (Usd Million)

Table 241 Japan: Ai In Biotechnology Market For Corporate Functions, By Type, 2022–2029 (Usd Million)

Table 242 Japan: Ai In Biotechnology Market, By Deployment Mode,

2022–2029 (Usd Million)

Table 243 Japan: Ai In Biotechnology Market For Cloud-based Solutions, By Type, 2022–2029 (Usd Million)

Table 244 Japan: Ai In Biotechnology Market, By End User,

2022–2029 (Usd Million)

Table 245 China: Ai In Biotechnology Market, By Offering, 2022–2029 (Usd Million)

Table 246 China: Ai In Biotechnology Market For Services, By Type,

2022–2029 (Usd Million)

Table 247 China: Ai In Biotechnology Market, By Function, 2022–2029 (Usd Million)

Table 248 China: Ai In Biotechnology Market For Research & Development Functions, By Type, 2022–2029 (Usd Million)

Table 249 China: Ai In Biotechnology Market For Drug Discovery, By Type,

2022–2029 (Usd Million)

Table 250 China: Ai In Biotechnology Market For Clinical Development, By Type, 2022–2029 (Usd Million)

Table 251 China: Ai In Biotechnology Market For Manufacturing & Supply Chain Functions, By Type, 2022–2029 (Usd Million)

Table 252 China: Ai In Biotechnology Market For Launch & Commercial Functions, By Type, 2022–2029 (Usd Million)

Table 253 China: Ai In Biotechnology Market, By Post-marketing Surveillance & Patient Support Functions, By Type, 2022–2029 (Usd Million)

Table 254 China: Ai In Biotechnology Market For Corporate Functions, By Type, 2022–2029 (Usd Million)

Table 255 China: Ai In Biotechnology Market, By Deployment Mode,

2022–2029 (Usd Million)

Table 256 China: Ai In Biotechnology Market For Cloud-based Solutions, By Type, 2022–2029 (Usd Million)

Table 257 China: Ai In Biotechnology Market, By End User,

2022–2029 (Usd Million)

Table 258 India: Ai In Biotechnology Market, By Offering, 2022–2029 (Usd Million)

Table 259 India: Ai In Biotechnology Market For Services, By Type,

2022–2029 (Usd Million)

Table 260 India: Ai In Biotechnology Market, By Function, 2022–2029 (Usd Million)

Table 261 India: Ai In Biotechnology Market For Research & Development Functions, By Type, 2022–2029 (Usd Million)

Table 262 India: Ai In Biotechnology Market For Drug Discovery, By Type,

2022–2029 (Usd Million)

Table 263 India: Ai In Biotechnology Market For Clinical Development, By Type, 2022–2029 (Usd Million)

Table 264 India: Ai In Biotechnology Market For Manufacturing & Supply Chain Functions, By Type, 2022–2029 (Usd Million)

Table 265 India: Ai In Biotechnology Market For Launch & Commercial Functions, By Type, 2022–2029 (Usd Million)

Table 266 India: Ai In Biotechnology Market For Post-marketing Surveillance & Patient Support Functions, By Type, 2022–2029 (Usd Million)

Table 267 India: Ai In Biotechnology Market For Corporate Functions, By Type, 2022–2029 (Usd Million)

Table 268 India: Ai In Biotechnology Market, By Deployment Mode,

2022–2029 (Usd Million)

Table 269 India: Ai In Biotechnology Market For Cloud-based Solutions, By Type, 2022–2029 (Usd Million)

Table 270 India: Ai In Biotechnology Market, By End User, 2022–2029 (Usd Million)

Table 271 South Korea: Ai In Biotechnology Market, By Offering,

2022–2029 (Usd Million)

Table 272 South Korea: Ai In Biotechnology Market For Services, By Type,

2022–2029 (Usd Million)

Table 273 South Korea: Ai In Biotechnology Market, By Function,

2022–2029 (Usd Million)

Table 274 South Korea: Ai In Biotechnology Market For Research & Development Functions, By Type, 2022–2029 (Usd Million)

Table 275 South Korea: Ai In Biotechnology Market For Drug Discovery, By Type, 2022–2029 (Usd Million)

Table 276 South Korea: Ai In Biotechnology Market For Clinical Development,

By Type, 2022–2029 (Usd Million)

Table 277 South Korea: Ai In Biotechnology Market For Manufacturing & Supply Chain Functions, By Type, 2022–2029 (Usd Million)

Table 278 South Korea: Ai In Biotechnology Market For Launch & Commercial Functions, By Type, 2022–2029 (Usd Million)

Table 279 South Korea: Ai In Biotechnology Market For Post-marketing Surveillance & Patient Support Functions, By Type,

2022–2029 (Usd Million)

Table 280 South Korea: Ai In Biotechnology Market For Corporate Functions,

By Type, 2022–2029 (Usd Million)

Table 281 South Korea: Ai In Biotechnology Market, By Deployment Mode,

2022–2029 (Usd Million)

Table 282 South Korea: Ai In Biotechnology Market For Cloud-based Solutions, By Type, 2022–2029 (Usd Million)

Table 283 South Korea: Ai In Biotechnology Market, By End User,

2022–2029 (Usd Million)

Table 284 Rest Of Asia Pacific: Ai In Biotechnology Market, By Offering,

2022–2029 (Usd Million)

Table 285 Rest Of Asia Pacific: Ai In Biotechnology Market For Services,

By Type, 2022–2029 (Usd Million)

Table 286 Rest Of Asia Pacific: Ai In Biotechnology Market, By Function,

2022–2029 (Usd Million)

Table 287 Rest Of Asia Pacific: Ai In Biotechnology Market For Research & Development Functions, By Type, 2022–2029 (Usd Million)

Table 288 Rest Of Asia Pacific: Ai In Biotechnology Market For Drug Discovery,

By Type, 2022–2029 (Usd Million)

Table 289 Rest Of Asia Pacific: Ai In Biotechnology Market For Clinical Development, By Type, 2022–2029 (Usd Million)

Table 290 Rest Of Asia Pacific: Ai In Biotechnology Market For Manufacturing & Supply Chain Functions, By Type, 2022–2029 (Usd Million)

Table 291 Rest Of Asia Pacific: Ai In Biotechnology Market For Launch & Commercial Functions, By Type, 2022–2029 (Usd Million)

Table 292 Rest Of Asia Pacific: Ai In Biotechnology Market For Post-marketing Surveillance & Patient Support Functions, By Type,

2022–2029 (Usd Million)

Table 293 Rest Of Asia Pacific: Ai In Biotechnology Market For Corporate Functions, By Type, 2022–2029 (Usd Million)

Table 294 Rest Of Asia Pacific: Ai In Biotechnology Market, By Deployment Mode, 2022–2029 (Usd Million)

Table 295 Rest Of Asia Pacific: Ai In Biotechnology Market For Cloud-based Solutions, By Type, 2022–2029 (Usd Million)

Table 296 Rest Of Asia Pacific: Ai In Biotechnology Market, By End User,

2022–2029 (Usd Million)

Table 297 Latin America: Ai In Biotechnology Market, By Country,

2022–2029 (Usd Million)

Table 298 Latin America: Ai In Biotechnology Market, By Offering,

2022–2029 (Usd Million)

Table 299 Latin America: Ai In Biotechnology Market For Services, By Type,

2022–2029 (Usd Million)

Table 300 Latin America: Ai In Biotechnology Market, By Function,

2022–2029 (Usd Million)

Table 301 Latin America: Ai In Biotechnology Market For Research & Development Functions, By Type, 2022–2029 (Usd Million)

Table 302 Latin America: Ai In Biotechnology Market For Drug Discovery, By Type, 2022–2029 (Usd Million)

Table 303 Latin America: Ai In Biotechnology Market For Clinical Development,

By Type, 2022–2029 (Usd Million)

Table 304 Latin America: Ai In Biotechnology Market For Manufacturing & Supply Chain Functions, By Type, 2022–2029 (Usd Million)

Table 305 Latin America: Ai In Biotechnology Market For Launch & Commercial Functions, By Type, 2022–2029 (Usd Million)

Table 306 Latin America: Ai In Biotechnology Market For Post-marketing Surveillance & Patient Support Functions, By Type,

2022–2029 (Usd Million)

Table 307 Latin America: Ai In Biotechnology Market For Corporate Functions,

By Type, 2022–2029 (Usd Million)

Table 308 Latin America: Ai In Biotechnology Market, By Deployment Mode,

2022–2029 (Usd Million)

Table 309 Latin America: Ai In Biotechnology Market For Cloud-based Solutions, By Type, 2022–2029 (Usd Million)

Table 310 Latin America: Ai In Biotechnology Market, By End User,

2022–2029 (Usd Million)

Table 311 Brazil: Ai In Biotechnology Market, By Offering,

2022–2029 (Usd Million)

Table 312 Brazil: Ai In Biotechnology Market For Services, By Type,

2022–2029 (Usd Million)

Table 313 Brazil: Ai In Biotechnology Market, By Function,

2022–2029 (Usd Million)

Table 314 Brazil: Ai In Biotechnology Market For Research & Development Functions, By Type, 2022–2029 (Usd Million)

Table 315 Brazil: Ai In Biotechnology Market For Drug Discovery, By Type,

2022–2029 (Usd Million)

Table 316 Brazil: Ai In Biotechnology Market For Clinical Development, By Type, 2022–2029 (Usd Million)

Table 317 Brazil: Ai In Biotechnology Market For Manufacturing & Supply Chain Functions, By Type, 2022–2029 (Usd Million)

Table 318 Brazil: Ai In Biotechnology Market For Launch & Commercial Functions, By Type, 2022–2029 (Usd Million)

Table 319 Brazil: Ai In Biotechnology Market For Post-marketing Surveillance & Patient Support Functions, By Type, 2022–2029 (Usd Million)

Table 320 Brazil: Ai In Biotechnology Market For Corporate Functions, By Type, 2022–2029 (Usd Million)

Table 321 Brazil: Ai In Biotechnology Market, By Deployment Mode,

2022–2029 (Usd Million)

Table 322 Brazil: Ai In Biotechnology Market For Cloud-based Solutions, By Type, 2022–2029 (Usd Million)

Table 323 Brazil: Ai In Biotechnology Market, By End User,

2022–2029 (Usd Million)

Table 324 Mexico: Ai In Biotechnology Market, By Offering,

2022–2029 (Usd Million)

Table 325 Mexico: Ai In Biotechnology Market For Services, By Type,

2022–2029 (Usd Million)

Table 326 Mexico: Ai In Biotechnology Market, By Function,

2022–2029 (Usd Million)

Table 327 Mexico: Ai In Biotechnology Market For Research & Development Functions, By Type, 2022–2029 (Usd Million)

Table 328 Mexico: Ai In Biotechnology Market For Drug Discovery, By Type,

2022–2029 (Usd Million)

Table 329 Mexico: Ai In Biotechnology Market For Clinical Development, By Type, 2022–2029 (Usd Million)

Table 330 Mexico: Ai In Biotechnology Market For Manufacturing & Supply Chain Functions, By Type, 2022–2029 (Usd Million)

Table 331 Mexico: Ai In Biotechnology Market For Launch & Commercial Functions, By Type, 2022–2029 (Usd Million)

Table 332 Mexico: Ai In Biotechnology Market For Post-marketing Surveillance & Patient Support Functions, By Type, 2022–2029 (Usd Million)

Table 333 Mexico: Ai In Biotechnology Market For Corporate Functions, By Type, 2022–2029 (Usd Million)

Table 334 Mexico: Ai In Biotechnology Market, By Deployment Mode,

2022–2029 (Usd Million)

Table 335 Mexico: Ai In Biotechnology Market For Cloud-based Solutions, By Type, 2022–2029 (Usd Million)

Table 336 Mexico: Ai In Biotechnology Market, By End User,

2022–2029 (Usd Million)

Table 337 Rest Of Latin America: Ai In Biotechnology Market, By Offering,

2022–2029 (Usd Million)

Table 338 Rest Of Latin America: Ai In Biotechnology Market For Services, By Type, 2022–2029 (Usd Million)

Table 339 Rest Of Latin America: Ai In Biotechnology Market, By Function,

2022–2029 (Usd Million)

Table 340 Rest Of Latin America: Ai In Biotechnology Market For Research & Development Functions, By Type, 2022–2029 (Usd Million)

Table 341 Rest Of Latin America: Ai In Biotechnology Market For Drug Discovery, By Type, 2022–2029 (Usd Million)

Table 342 Rest Of Latin America: Ai In Biotechnology Market For Clinical Development, By Type, 2022–2029 (Usd Million)

Table 343 Rest Of Latin America: Ai In Biotechnology Market For Manufacturing & Supply Chain Functions, By Type, 2022–2029 (Usd Million)

Table 344 Rest Of Latin America: Ai In Biotechnology Market For Launch & Commercial Functions, By Type, 2022–2029 (Usd Million)

Table 345 Rest Of Latin America: Ai In Biotechnology Market For Post-marketing Surveillance & Patient Support Functions, By Type,

2022–2029 (Usd Million)

Table 346 Rest Of Latin America: Ai In Biotechnology Market For Corporate Functions, By Type, 2022–2029 (Usd Million)

Table 347 Rest Of Latin America: Ai In Biotechnology Market, By Deployment Mode, 2022–2029 (Usd Million)

Table 348 Rest Of Latin America: Ai In Biotechnology Market For Cloud-based Solutions, By Type, 2022–2029 (Usd Million)

Table 349 Rest Of Latin America: Ai In Biotechnology Market, By End User,

2022–2029 (Usd Million)

Table 350 Middle East & Africa: Ai In Biotechnology Market, By Country,

2022–2029 (Usd Million)

Table 351 Middle East & Africa: Ai In Biotechnology Market, By Offering,

2022–2029 (Usd Million)

Table 352 Middle East & Africa: Ai In Biotechnology Market For Services,

By Type, 2022–2029 (Usd Million)

Table 353 Middle East & Africa: Ai In Biotechnology Market, By Function,

2022–2029 (Usd Million)

Table 354 Middle East & Africa: Ai In Biotechnology Market For Research & Development Functions, By Type, 2022–2029 (Usd Million)

Table 355 Middle East & Africa: Ai In Biotechnology Market For Drug Discovery, By Type, 2022–2029 (Usd Million)

Table 356 Middle East & Africa: Ai In Biotechnology Market For Clinical Development, By Type, 2022–2029 (Usd Million)

Table 357 Middle East & Africa: Ai In Biotechnology Market For Manufacturing & Supply Chain Functions, By Type, 2022–2029 (Usd Million)

Table 358 Middle East & Africa: Ai In Biotechnology Market For Launch & Commercial Functions, By Type, 2022–2029 (Usd Million)

Table 359 Middle East & Africa: Ai In Biotechnology Market For Post-marketing Surveillance & Patient Support Functions, By Type,

2022–2029 (Usd Million)

Table 360 Middle East & Africa: Ai In Biotechnology Market For Corporate Functions, By Type, 2022–2029 (Usd Million)

Table 361 Middle East & Africa: Ai In Biotechnology Market, By Deployment Mode, 2022–2029 (Usd Million)

Table 362 Middle East & Africa: Ai In Biotechnology Market For Cloud-based Solutions, By Type, 2022–2029 (Usd Million)

Table 363 Middle East & Africa: Ai In Biotechnology Market, By End User,

2022–2029 (Usd Million)

Table 364 Gcc Countries: Ai In Biotechnology Market, By Offering,

2022–2029 (Usd Million)

Table 365 Gcc Countries: Ai In Biotechnology Market For Services, By Type,

2022–2029 (Usd Million)

Table 366 Gcc Countries: Ai In Biotechnology Market, By Function,

2022–2029 (Usd Million)

Table 367 Gcc Countries: Ai In Biotechnology Market For Research & Development Functions, By Type, 2022–2029 (Usd Million)

Table 368 Gcc Countries: Ai In Biotechnology Market For Drug Discovery, By Type, 2022–2029 (Usd Million)

Table 369 Gcc Countries: Ai In Biotechnology Market For Clinical Development, By Type, 2022–2029 (Usd Million)

Table 370 Gcc Countries: Ai In Biotechnology Market For Manufacturing & Supply Chain Functions, By Type, 2022–2029 (Usd Million)

Table 371 Gcc Countries: Ai In Biotechnology Market For Launch & Commercial Functions, By Type, 2022–2029 (Usd Million)

Table 372 Gcc Countries: Ai In Biotechnology Market For Post-marketing Surveillance & Patient Support Functions, By Type,

2022–2029 (Usd Million)

Table 373 Gcc Countries: Ai In Biotechnology Market For Corporate Functions, By Type, 2022–2029 (Usd Million)

Table 374 Gcc Countries: Ai In Biotechnology Market, By Deployment Mode,

2022–2029 (Usd Million)

Table 375 Gcc Countries: Ai In Biotechnology Market For Cloud-based Solutions, By Type, 2022–2029 (Usd Million)

Table 376 Gcc Countries: Ai In Biotechnology Market, By End User,

2022–2029 (Usd Million)

Table 377 Rest Of Middle East & Africa: Ai In Biotechnology Market, By Offering, 2022–2029 (Usd Million)

Table 378 Rest Of Middle East & Africa: Ai In Biotechnology Market For Services, By Type, 2022–2029 (Usd Million)

Table 379 Rest Of Middle East & Africa: Ai In Biotechnology Market, By Function, 2022–2029 (Usd Million)

Table 380 Rest Of Middle East & Africa: Ai In Biotechnology Market For Research & Development Functions, By Type, 2022–2029 (Usd Million)

Table 381 Rest Of Middle East & Africa: Ai In Biotechnology Market For Drug Discovery, By Type, 2022–2029 (Usd Million)

Table 382 Rest Of Middle East & Africa: Ai In Biotechnology Market For Clinical Development, By Type, 2022–2029 (Usd Million)

Table 383 Rest Of Middle East & Africa: Ai In Biotechnology Market For Manufacturing & Supply Chain Functions, By Type,

2022–2029 (Usd Million)

Table 384 Rest Of Middle East & Africa: Ai In Biotechnology Market For Launch & Commercial Functions, By Type, 2022–2029 (Usd Million)

Table 385 Rest Of Middle East & Africa: Ai In Biotechnology Market For Post-marketing Surveillance & Patient Support Functions, By Type,

2022–2029 (Usd Million)

Table 386 Rest Of Middle East & Africa: Ai In Biotechnology Market For Corporate Functions, By Type, 2022–2029 (Usd Million)

Table 387 Rest Of Middle East & Africa: Ai In Biotechnology Market,

By Deployment Mode, 2022–2029 (Usd Million)

Table 388 Rest Of Middle East & Africa: Ai In Biotechnology Market For

Cloud-based Solutions Mode, By Type, 2022–2029 (Usd Million)

Table 389 Rest Of Middle East & Africa: Ai In Biotechnology Market, By End User, 2022–2029 (Usd Million)

Table 390 Ai In Biotechnology: Degree Of Competition

Table 391 Ai In Biotechnology Market: Offering Footprint

Table 392 Ai In Biotechnology Market: Function Footprint

Table 393 Ai In Biotechnology Market: End-user Footprint

Table 394 Ai In Biotechnology: Region Footprint

Table 395 Ai In Biotechnology Market: Detailed List Of Key Start-ups/Smes

Table 396 Ai In Biotechnology: Competitive Benchmarking Of Key Emerging Players/Startups

Table 397 Ai In Biotechnology Market: Product Launches & Upgrades,

January 2021–august 2024

Table 398 Ai In Biotechnology Market: Deals, January 2021–august 2024

Table 399 Ai In Biotechnology Market: Expansions, January 2021–august 2024

Table 400 Nvidia Corporation: Company Overview

Table 401 Nvidia Corporation: Products Offered

Table 402 Nvidia Corporation: Product Launches, January 2021−august 2024

Table 403 Nvidia Corporation: Deals, January 2021−august 2024

Table 404 Illumina, Inc.: Company Overview

Table 405 Illumina, Inc.: Products Offered

Table 406 Illumina, Inc.: Product Launches, January 2021−august 2024

Table 407 Illumina, Inc.: Deals, January 2021−august 2024

Table 408 Exscientia: Company Overview

Table 409 Exscientia: Products Offered

Table 410 Exscientia: Product Launches, January 2021−august 2024

Table 411 Exscientia: Deals, January 2021−august 2024

Table 412 Exscientia: Other Developments, January 2021−august 2024

Table 413 Schrödinger, Inc.: Company Overview

Table 414 Schrödinger, Inc.: Products Offered

Table 415 Schrödinger, Inc.: Product Upgrades, January 2021−august 2024

Table 416 Schrödinger, Inc.: Deals, January 2021−august 2024

Table 417 Recursion Pharmaceuticals, Inc.: Company Overview

Table 418 Recursion Pharmaceuticals, Inc.: Products Offered

Table 419 Recursion Pharmaceuticals, Inc.: Deals, January 2021−august 2024

Table 420 Recursion Pharmaceuticals, Inc.: Expansions,

January 2021−august 2024

Table 421 Sophia Genetics: Company Overview

Table 422 Sophia Genetics: Products Offered

Table 423 Sophia Genetics: Product Launches, January 2021−august 2024

Table 424 Sophia Genetics: Deals, January 2021−august 2024

Table 425 Predictive Oncology: Company Overview

Table 426 Predictive Oncology: Products Offered

Table 427 Predictive Oncology: Product Launches, January 2021−august 2024

Table 428 Predictive Oncology: Deals, January 2021−august 2024

Table 429 Benevolentai: Company Overview

Table 430 Benevolentai: Products Offered

Table 431 Benevolentai: Deals, January 2021−august 2024

Table 432 Eurofins Discovery: Company Overview

Table 433 Eurofins Discovery: Products Offered

Table 434 Eurofins Discovery: Product Launches, January 2021−august 2024

Table 435 Eurofins Discovery: Deals, January 2021−august 2024

Table 436 Eurofins Discovery: Expansions, January 2021−august 2024

Table 437 Xtalpi Inc.: Company Overview

Table 438 Xtalpi Inc.: Products Offered

Table 439 Xtalpi Inc.: Deals, January 2021−august 2024

Table 440 Dnanexus, Inc.: Company Overview

Table 441 Dnanexus, Inc.: Products Offered

Table 442 Dnanexus, Inc.: Deals, January 2021−august 2024

Table 443 Dnanexus, Inc: Other Developments, January 2021–august 2024

Table 444 Numedii, Inc.: Company Overview

Table 445 Numedii, Inc.: Products Offered

Table 446 Bpgbio, Inc.: Company Overview

Table 447 Bpgbio, Inc.: Products Offered

Table 448 Bpgbio, Inc.: Deals, January 2021−august 2024

Table 449 Iktos: Company Overview

Table 450 Iktos: Products Offered

Table 451 Iktos: Deals, January 2021−august 2024

Table 452 Insilico Medicine: Company Overview

Table 453 Insilico Medicine: Products Offered

Table 454 Logica: Company Overview

Table 455 Logica: Products Offered

Table 456 American Chemical Society: Company Overview

Table 457 American Chemical Society: Products Offered

Table 458 Aganitha Ai Inc.: Company Overview

Table 459 Aganitha Ai Inc.: Products Offered

Table 460 Aganitha Ai Inc.: Deals, January 2021−august 2024

Figures List

Figure 1 Ai In Biotechnology Market Segmentation & Regional Scope

Figure 2 Research Design

Figure 3 Primary Sources

Figure 4 Breakdown Of Primary Interviews (Demand Side): By Company Type, Designation, And Region

Figure 5 Market Size Estimation: Revenue Share Analysis

Figure 6 Top-down Approach

Figure 7 Ai In Biotechnology Market: Cagr Projections

Figure 8 Cagr Projections: Supply-side Analysis

Figure 9 Data Triangulation

Figure 10 Ai In Biotechnology Market, By Offering, 2024 Vs. 2029 (Usd Million)

Figure 11 Ai In Biotechnology Market, By Function, 2024 Vs. 2029 (Usd Million)

Figure 12 Ai In Biotechnology Market, By Deployment Mode,

2024 Vs. 2029 (Usd Million)

Figure 13 Ai In Biotechnology Market, By End User, 2024 Vs. 2029 (Usd Million)

Figure 14 Ai In Biotechnology Market: Geographical Snapshot

Figure 15 Growing Focus On Cost-effective Processes And Favorable Government Support And Funding To Drive Market

Figure 16 North America To Dominate Ai In Biotechnology Market During Forecast Period

Figure 17 Pharmaceutical Companies In North America Accounted For Largest Market Share In 2023

Figure 18 India To Register Highest Growth Rate During Forecast Period

Figure 19 Emerging Economies To Register Higher Growth Rates During Forecast Period

Figure 20 Ai In Biotechnology Market: Drivers, Restraints, Opportunities,

And Challenges

Figure 21 Ai In Biotechnology Market: Ecosystem Analysis

Figure 22 Ai In Biotechnology Market: Value Chain Analysis

Figure 23 Ai In Biotechnology Market: Porter’s Five Forces Analysis

Figure 24 Patent Publication Trends In Ai In Biotechnology Market, 2015–2024

Figure 25 Patent Analysis Of Ai In Biotechnology Market,

January 2015–august 2024

Figure 26 Evolution Of Ai In Biotechnology Market

Figure 27 Influence Of Stakeholders On Buying Process Of Top 3 End Users

Figure 28 Key Buying Criteria For Top 3 End Users

Figure 29 Trends & Disruptions Impacting Customers’ Businesses

Figure 30 Ai In Biotechnology Market: Investment & Funding Scenario

Figure 31 Market Potential Of Ai/Generative Ai On Ai In Biotechnology Solutions

Figure 32 Number Of Ai-discovered Molecules In Clinical Trials

Figure 33 North America: Ai In Biotechnology Market Snapshot

Figure 34 Asia Pacific: Ai In Biotechnology Market Snapshot

Figure 35 Key Developments Of Major Players Between

January 2021 And June 2024

Figure 36 Revenue Analysis Of Key Players In Ai In Biotechnology Market,

2019–2023 (Usd Billion)

Figure 37 Market Share Analysis Of Key Players In Ai In Biotechnology Market (2023)

Figure 38 Ranking Of Key Players In Ai In Biotechnology Market, 2023

Figure 39 Ai In Biotechnology Market: Company Evaluation Matrix

(Key Players), 2023

Figure 40 Ai In Biotechnology Market: Company Footprint

Figure 41 Ai In Biotechnology Market: Company Evaluation Matrix

(Start-ups/Smes), 2023

Figure 42 Ev/Ebitda Of Key Vendors

Figure 43 Year-to-date (Ytd) Price Total Return And 5-year Stock Beta Of

Ai In Biotehnology Solution Vendors

Figure 44 Ai In Biotechnology Market: Brand/Product Comparative Analysis

Figure 45 Nvidia Corporation: Company Snapshot (2024)

Figure 46 Illumina, Inc.: Company Snapshot (2023)

Figure 47 Exscientia: Company Snapshot (2023)

Figure 48 Schrödinger, Inc.: Company Snapshot (2023)

Figure 49 Recursion Pharmaceuticals, Inc.: Company Snapshot (2023)

Figure 50 Sophia Genetics: Company Snapshot (2022)

Figure 51 Predictive Oncology: Company Snapshot (2023)

Figure 52 Benevolentai: Company Snapshot (2023)

Figure 53 Eurofins Discovery: Company Snapshot (2023)

Figure 54 Xtalpi Inc.: Company Snapshot (2023)